Marshall Wace’s Vigil Neuroscience VIGL Stock Holding History

Marshall Wace’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-25,900	Closed	-$206K	–	3447
2025 Q2	$206K	Sell	25,900 -451,034	-95%	-$2.02M	﹤0.01%	2450
2025 Q1	$849K	Buy	476,934 +210,039	+79%	+$471K	﹤0.01%	1858
2024 Q4	$454K	Buy	266,895 +122,853	+85%	+$363K	﹤0.01%	2074
2024 Q3	$490K	Buy	+144,042	New	+$534K	﹤0.01%	1923

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Marshall Wace's VIGL Position: Q3 2025 in Review

Marshall Wace sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 25,900 shares — an estimated $206K sold.

Marshall Wace first reported a position in VIGL in Q3 2024 and held it in 4 quarters. The position peaked at $849K in Q1 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Marshall Wace reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Marshall Wace sold 25,900 Vigil Neuroscience shares in Q3 2025, an estimated $206K.
Marshall Wace first reported a position in Vigil Neuroscience in Q3 2024 and held it in 4 quarters.
Marshall Wace's Vigil Neuroscience position peaked at $849K in Q1 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.